Xention
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Unit 3 Iconix Park London Rd, Sawston, C...Phone Number
+44 1223493900Website
www.xention.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Xention
Xention is a leader in the discovery and development of ion channel-modulating drugs. The Company is developing a pipeline of innovative products for the treatment of atrial fibrillation, an indication for which there is high unmet medical need, by targeting key ion channels. Xention uses an innovative approach to discover and design potent and selective small-molecule drugs and has collaborations with several companies. In atrial fibrillation, the company is developing modulators of Kv1.5 and Kir3.1/3.4 (IKACh), both recognised as novel, highly exciting new targets for the disease. Its Kv1.5 programme is the subject of a partnership with Servier for all territories except the US and Japan.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Xention your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Xention, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Xention had a recent Job posting/layoffs
Product Launch: Get notified when Xention launches new products
Check out if Xention is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Xention
Earning: See what the market has to say on Xention recently announced quarterly report
Check if Xention has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Xention has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Xention
Compare insights from companies similar to Xention, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Xention
<$5M
11-50
Private
$44.9M
2001
N/A
Company Profile Activity
Activity Insights
Xention is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Xention is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Xention.
Xention financials insights
Gather financial insights about Xention, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2003
Series A
$5.7M
Series C
$6.5M
2005
Series B
$20M
2010
Series D
$12.7M
Xention Tech Stack
A closer look at the technologies used by Xention
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Xention
Sign Up For FreeTo access detailed company insights
Xention is a leader in the discovery and development of ion channel-modulating drugs. The Company is developing a pipeline of innovative products for the treatment of atrial fibrillation, an indication for which there is high unmet medical need, by targeting key ion channels. Xention uses an innovative approach to discover and design potent and sel... Read More
